Will Jazz Pharmaceuticals Dance Up The Chart?

BY CHRISTINA WISE, INVESTOR'S BUSINESS DAILY

10/09/2014 12:15 PM ET

Today we're going to look at Jazz Pharmaceuticals (JAZZ), which specializes in treatments for narcolepsy and rare diseases. In 2012, the company merged with Azure Pharma and moved its tax domicile to Ireland. Analysts say that shift has given Jazz more room to grow. The lower corporate tax rate has reportedly helped the company maximize its cash flow and make acquisitions. Key Fundamentals The ...

IBD Stock Analysis is a subscriber feature. Take a free trial now to get instant access.

Try the Digital + Weekly Print Combo and enjoy the best of both worlds!
eIBD is available after market close to give you a head start on the next day's market action. Plus, you get the Weekly Special print edition delivered right to your home or office!

Enter in your information (* Required fields)

Your Email Address* **

Confirm Email Address* **

Password*(a - z, 0-9) **

First Name* *

Last Name* *

Country* *

Zip/Postal Code* **

Registration Benefits

1 2 3 4

IBD Forums

Participate in an IBD Forum and connect with other IBD subscribers.
IBD Screen Center

Access six valuable screens that show you top stocks in different categories.
My Stock Lists

Get customized stock lists to track your portfolio, watch lists and more!
My Routine

Create shortcuts to your favorite Investors.com features.

NEED TO REGISTER?:

I am a current subscriber and need to register on
Investors.com.

I am not a current subscriber and want to register
for free membership on Investors.com.

Partner Center

: COPYRIGHT AND TRADEMARK NOTICE | PRIVACY | TERMS OF USE

© 2024 Investor's Business Daily, LLC. All rights reserved.

Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. The information and content are subject to change without notice. You may use IBD Services and Subscriber-Only features solely for personal, non-commercial use. Removal or alteration of any trademark, copyright or other notices is strictly prohibited. You may not distribute IBD’s Services or Subscriber-Only features to others, whether or not for payment or other consideration, and you may not modify, copy, frame, reproduce, sell, publish, transmit, display or otherwise use or revise any portion of IBD’s Services or Subscriber-Only features.

Will Jazz Pharmaceuticals Dance Up The Chart?

Enter in your information (* Required fields)

Partner Center

About Investor's Business Daily